nodes	percent_of_prediction	percent_of_DWPC	metapath
Moxifloxacin—TOP2A—Vindesine—Vinblastine—head and neck cancer	0.0136	0.317	CbGdCrCtD
Moxifloxacin—TOP2A—Paclitaxel—Docetaxel—head and neck cancer	0.0134	0.311	CbGdCrCtD
Moxifloxacin—TOP2A—Vinorelbine—Vinblastine—head and neck cancer	0.00861	0.2	CbGdCrCtD
Moxifloxacin—TOP2A—Vincristine—Vinblastine—head and neck cancer	0.00736	0.171	CbGdCrCtD
Moxifloxacin—TOP2A—G0 and Early G1—CCNA1—head and neck cancer	0.00469	0.18	CbGpPWpGaD
Moxifloxacin—TOP2A—Gastric Cancer Network 1—CCNA1—head and neck cancer	0.00417	0.16	CbGpPWpGaD
Moxifloxacin—Hepatocellular injury—Docetaxel—head and neck cancer	0.00332	0.00357	CcSEcCtD
Moxifloxacin—Injection site reaction—Docetaxel—head and neck cancer	0.0033	0.00355	CcSEcCtD
Moxifloxacin—Haemoglobin—Hydroxyurea—head and neck cancer	0.00323	0.00347	CcSEcCtD
Moxifloxacin—Haemorrhage—Hydroxyurea—head and neck cancer	0.00321	0.00345	CcSEcCtD
Moxifloxacin—Hallucination—Hydroxyurea—head and neck cancer	0.0032	0.00343	CcSEcCtD
Moxifloxacin—Colitis—Docetaxel—head and neck cancer	0.00319	0.00343	CcSEcCtD
Moxifloxacin—Cardiac arrest—Fluorouracil—head and neck cancer	0.00318	0.00341	CcSEcCtD
Moxifloxacin—Candida infection—Docetaxel—head and neck cancer	0.00317	0.00341	CcSEcCtD
Moxifloxacin—Neuropathy—Docetaxel—head and neck cancer	0.00312	0.00335	CcSEcCtD
Moxifloxacin—Dry skin—Fluorouracil—head and neck cancer	0.00306	0.00329	CcSEcCtD
Moxifloxacin—Oesophagitis—Docetaxel—head and neck cancer	0.00304	0.00326	CcSEcCtD
Moxifloxacin—Neoplasm—Docetaxel—head and neck cancer	0.00301	0.00323	CcSEcCtD
Moxifloxacin—Muscular weakness—Fluorouracil—head and neck cancer	0.00295	0.00317	CcSEcCtD
Moxifloxacin—Angiopathy—Hydroxyurea—head and neck cancer	0.00291	0.00313	CcSEcCtD
Moxifloxacin—Dysphagia—Fluorouracil—head and neck cancer	0.00289	0.0031	CcSEcCtD
Moxifloxacin—Sepsis—Docetaxel—head and neck cancer	0.00288	0.0031	CcSEcCtD
Moxifloxacin—Chills—Hydroxyurea—head and neck cancer	0.00288	0.0031	CcSEcCtD
Moxifloxacin—Eosinophilia—Fluorouracil—head and neck cancer	0.00286	0.00307	CcSEcCtD
Moxifloxacin—Ill-defined disorder—Vinblastine—head and neck cancer	0.00285	0.00306	CcSEcCtD
Moxifloxacin—Anaemia—Vinblastine—head and neck cancer	0.00283	0.00304	CcSEcCtD
Moxifloxacin—Angina pectoris—Fluorouracil—head and neck cancer	0.00281	0.00302	CcSEcCtD
Moxifloxacin—Phlebitis—Docetaxel—head and neck cancer	0.0028	0.00301	CcSEcCtD
Moxifloxacin—Erythema—Hydroxyurea—head and neck cancer	0.0028	0.003	CcSEcCtD
Moxifloxacin—Thrombophlebitis—Docetaxel—head and neck cancer	0.00279	0.00299	CcSEcCtD
Moxifloxacin—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.00277	0.00298	CcSEcCtD
Moxifloxacin—Malaise—Vinblastine—head and neck cancer	0.00277	0.00297	CcSEcCtD
Moxifloxacin—Vertigo—Vinblastine—head and neck cancer	0.00276	0.00296	CcSEcCtD
Moxifloxacin—Leukopenia—Vinblastine—head and neck cancer	0.00275	0.00295	CcSEcCtD
Moxifloxacin—Pancytopenia—Fluorouracil—head and neck cancer	0.00274	0.00295	CcSEcCtD
Moxifloxacin—Deafness—Docetaxel—head and neck cancer	0.0027	0.0029	CcSEcCtD
Moxifloxacin—Hepatic failure—Docetaxel—head and neck cancer	0.00268	0.00288	CcSEcCtD
Moxifloxacin—Cardiac failure congestive—Docetaxel—head and neck cancer	0.00266	0.00286	CcSEcCtD
Moxifloxacin—Convulsion—Vinblastine—head and neck cancer	0.00266	0.00285	CcSEcCtD
Moxifloxacin—Hypertension—Vinblastine—head and neck cancer	0.00265	0.00284	CcSEcCtD
Moxifloxacin—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.00264	0.00283	CcSEcCtD
Moxifloxacin—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.0026	0.00279	CcSEcCtD
Moxifloxacin—Pneumonia—Fluorouracil—head and neck cancer	0.00259	0.00278	CcSEcCtD
Moxifloxacin—Anaemia—Hydroxyurea—head and neck cancer	0.00259	0.00278	CcSEcCtD
Moxifloxacin—Discomfort—Vinblastine—head and neck cancer	0.00258	0.00277	CcSEcCtD
Moxifloxacin—Infestation NOS—Fluorouracil—head and neck cancer	0.00258	0.00277	CcSEcCtD
Moxifloxacin—Infestation—Fluorouracil—head and neck cancer	0.00258	0.00277	CcSEcCtD
Moxifloxacin—Visual disturbance—Docetaxel—head and neck cancer	0.00255	0.00273	CcSEcCtD
Moxifloxacin—Atrial fibrillation—Docetaxel—head and neck cancer	0.00255	0.00273	CcSEcCtD
Moxifloxacin—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00254	0.00273	CcSEcCtD
Moxifloxacin—Renal impairment—Docetaxel—head and neck cancer	0.00254	0.00272	CcSEcCtD
Moxifloxacin—Myocardial infarction—Fluorouracil—head and neck cancer	0.00253	0.00271	CcSEcCtD
Moxifloxacin—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00253	0.00271	CcSEcCtD
Moxifloxacin—Dermatitis bullous—Docetaxel—head and neck cancer	0.00252	0.00271	CcSEcCtD
Moxifloxacin—Malaise—Hydroxyurea—head and neck cancer	0.00252	0.00271	CcSEcCtD
Moxifloxacin—Stomatitis—Fluorouracil—head and neck cancer	0.00251	0.0027	CcSEcCtD
Moxifloxacin—Urinary tract infection—Fluorouracil—head and neck cancer	0.0025	0.00269	CcSEcCtD
Moxifloxacin—Conjunctivitis—Fluorouracil—head and neck cancer	0.0025	0.00269	CcSEcCtD
Moxifloxacin—Leukopenia—Hydroxyurea—head and neck cancer	0.0025	0.00269	CcSEcCtD
Moxifloxacin—Cardiac failure—Docetaxel—head and neck cancer	0.00247	0.00266	CcSEcCtD
Moxifloxacin—Lethargy—Docetaxel—head and neck cancer	0.00246	0.00264	CcSEcCtD
Moxifloxacin—Thrombocytopenia—Vinblastine—head and neck cancer	0.00245	0.00263	CcSEcCtD
Moxifloxacin—Epistaxis—Fluorouracil—head and neck cancer	0.00243	0.00261	CcSEcCtD
Moxifloxacin—Convulsion—Hydroxyurea—head and neck cancer	0.00242	0.0026	CcSEcCtD
Moxifloxacin—Sinusitis—Fluorouracil—head and neck cancer	0.00242	0.0026	CcSEcCtD
Moxifloxacin—Pain in extremity—Docetaxel—head and neck cancer	0.00241	0.00259	CcSEcCtD
Moxifloxacin—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.00241	0.00259	CcSEcCtD
Moxifloxacin—Agranulocytosis—Fluorouracil—head and neck cancer	0.0024	0.00258	CcSEcCtD
Moxifloxacin—Anorexia—Vinblastine—head and neck cancer	0.00239	0.00256	CcSEcCtD
Moxifloxacin—Migraine—Docetaxel—head and neck cancer	0.00237	0.00255	CcSEcCtD
Moxifloxacin—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00236	0.00254	CcSEcCtD
Moxifloxacin—Discomfort—Hydroxyurea—head and neck cancer	0.00235	0.00253	CcSEcCtD
Moxifloxacin—Haemoglobin—Fluorouracil—head and neck cancer	0.00232	0.0025	CcSEcCtD
Moxifloxacin—Rhinitis—Fluorouracil—head and neck cancer	0.00232	0.00249	CcSEcCtD
Moxifloxacin—Haemorrhage—Fluorouracil—head and neck cancer	0.00231	0.00248	CcSEcCtD
Moxifloxacin—Hypoaesthesia—Fluorouracil—head and neck cancer	0.0023	0.00247	CcSEcCtD
Moxifloxacin—Pharyngitis—Fluorouracil—head and neck cancer	0.0023	0.00247	CcSEcCtD
Moxifloxacin—Oedema—Hydroxyurea—head and neck cancer	0.00228	0.00245	CcSEcCtD
Moxifloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—YAP1—head and neck cancer	0.00228	0.0873	CbGpPWpGaD
Moxifloxacin—Paraesthesia—Vinblastine—head and neck cancer	0.00225	0.00241	CcSEcCtD
Moxifloxacin—Dehydration—Docetaxel—head and neck cancer	0.00224	0.00241	CcSEcCtD
Moxifloxacin—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00224	0.0024	CcSEcCtD
Moxifloxacin—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00223	0.0024	CcSEcCtD
Moxifloxacin—Liver function test abnormal—Docetaxel—head and neck cancer	0.00223	0.00239	CcSEcCtD
Moxifloxacin—Skin disorder—Hydroxyurea—head and neck cancer	0.00222	0.00238	CcSEcCtD
Moxifloxacin—Dry skin—Docetaxel—head and neck cancer	0.00221	0.00238	CcSEcCtD
Moxifloxacin—Orthostatic hypotension—Docetaxel—head and neck cancer	0.0022	0.00237	CcSEcCtD
Moxifloxacin—Abdominal pain upper—Docetaxel—head and neck cancer	0.0022	0.00237	CcSEcCtD
Moxifloxacin—Breast disorder—Docetaxel—head and neck cancer	0.00218	0.00234	CcSEcCtD
Moxifloxacin—Anorexia—Hydroxyurea—head and neck cancer	0.00218	0.00234	CcSEcCtD
Moxifloxacin—Decreased appetite—Vinblastine—head and neck cancer	0.00218	0.00234	CcSEcCtD
Moxifloxacin—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.00217	0.00233	CcSEcCtD
Moxifloxacin—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.00217	0.00233	CcSEcCtD
Moxifloxacin—Cramp muscle—Docetaxel—head and neck cancer	0.00217	0.00233	CcSEcCtD
Moxifloxacin—Constipation—Vinblastine—head and neck cancer	0.00214	0.0023	CcSEcCtD
Moxifloxacin—Pain—Vinblastine—head and neck cancer	0.00214	0.0023	CcSEcCtD
Moxifloxacin—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.00213	0.00229	CcSEcCtD
Moxifloxacin—Dysphagia—Docetaxel—head and neck cancer	0.00209	0.00224	CcSEcCtD
Moxifloxacin—Arrhythmia—Fluorouracil—head and neck cancer	0.00207	0.00222	CcSEcCtD
Moxifloxacin—Feeling abnormal—Vinblastine—head and neck cancer	0.00206	0.00222	CcSEcCtD
Moxifloxacin—Bronchospasm—Docetaxel—head and neck cancer	0.00205	0.0022	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00205	0.0022	CcSEcCtD
Moxifloxacin—Dyspnoea—Hydroxyurea—head and neck cancer	0.00204	0.00219	CcSEcCtD
Moxifloxacin—Angina pectoris—Docetaxel—head and neck cancer	0.00203	0.00218	CcSEcCtD
Moxifloxacin—Somnolence—Hydroxyurea—head and neck cancer	0.00203	0.00218	CcSEcCtD
Moxifloxacin—Erythema—Fluorouracil—head and neck cancer	0.00201	0.00216	CcSEcCtD
Moxifloxacin—Dyspepsia—Hydroxyurea—head and neck cancer	0.00201	0.00216	CcSEcCtD
Moxifloxacin—Decreased appetite—Hydroxyurea—head and neck cancer	0.00198	0.00213	CcSEcCtD
Moxifloxacin—Pancytopenia—Docetaxel—head and neck cancer	0.00198	0.00213	CcSEcCtD
Moxifloxacin—Abdominal pain—Vinblastine—head and neck cancer	0.00198	0.00213	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00197	0.00212	CcSEcCtD
Moxifloxacin—Fatigue—Hydroxyurea—head and neck cancer	0.00197	0.00211	CcSEcCtD
Moxifloxacin—Pain—Hydroxyurea—head and neck cancer	0.00195	0.0021	CcSEcCtD
Moxifloxacin—Constipation—Hydroxyurea—head and neck cancer	0.00195	0.0021	CcSEcCtD
Moxifloxacin—Neutropenia—Docetaxel—head and neck cancer	0.00195	0.00209	CcSEcCtD
Moxifloxacin—Weight increased—Docetaxel—head and neck cancer	0.0019	0.00204	CcSEcCtD
Moxifloxacin—Vision blurred—Fluorouracil—head and neck cancer	0.0019	0.00204	CcSEcCtD
Moxifloxacin—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00188	0.00202	CcSEcCtD
Moxifloxacin—Pneumonia—Docetaxel—head and neck cancer	0.00187	0.00201	CcSEcCtD
Moxifloxacin—Anaemia—Fluorouracil—head and neck cancer	0.00186	0.002	CcSEcCtD
Moxifloxacin—Infestation NOS—Docetaxel—head and neck cancer	0.00186	0.002	CcSEcCtD
Moxifloxacin—Infestation—Docetaxel—head and neck cancer	0.00186	0.002	CcSEcCtD
Moxifloxacin—Hypersensitivity—Vinblastine—head and neck cancer	0.00184	0.00198	CcSEcCtD
Moxifloxacin—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.00184	0.00198	CcSEcCtD
Moxifloxacin—Acute coronary syndrome—Docetaxel—head and neck cancer	0.00183	0.00197	CcSEcCtD
Moxifloxacin—Renal failure—Docetaxel—head and neck cancer	0.00183	0.00196	CcSEcCtD
Moxifloxacin—Myocardial infarction—Docetaxel—head and neck cancer	0.00182	0.00196	CcSEcCtD
Moxifloxacin—Neuropathy peripheral—Docetaxel—head and neck cancer	0.00182	0.00196	CcSEcCtD
Moxifloxacin—Jaundice—Docetaxel—head and neck cancer	0.00181	0.00195	CcSEcCtD
Moxifloxacin—Stomatitis—Docetaxel—head and neck cancer	0.00181	0.00195	CcSEcCtD
Moxifloxacin—Conjunctivitis—Docetaxel—head and neck cancer	0.00181	0.00194	CcSEcCtD
Moxifloxacin—Body temperature increased—Hydroxyurea—head and neck cancer	0.0018	0.00194	CcSEcCtD
Moxifloxacin—Leukopenia—Fluorouracil—head and neck cancer	0.0018	0.00194	CcSEcCtD
Moxifloxacin—Asthenia—Vinblastine—head and neck cancer	0.0018	0.00193	CcSEcCtD
Moxifloxacin—Hepatobiliary disease—Docetaxel—head and neck cancer	0.00176	0.00189	CcSEcCtD
Moxifloxacin—Epistaxis—Docetaxel—head and neck cancer	0.00175	0.00188	CcSEcCtD
Moxifloxacin—Convulsion—Fluorouracil—head and neck cancer	0.00174	0.00187	CcSEcCtD
Moxifloxacin—Agranulocytosis—Docetaxel—head and neck cancer	0.00174	0.00186	CcSEcCtD
Moxifloxacin—Chest pain—Fluorouracil—head and neck cancer	0.00171	0.00184	CcSEcCtD
Moxifloxacin—Myalgia—Fluorouracil—head and neck cancer	0.00171	0.00184	CcSEcCtD
Moxifloxacin—Diarrhoea—Vinblastine—head and neck cancer	0.00171	0.00184	CcSEcCtD
Moxifloxacin—Discomfort—Fluorouracil—head and neck cancer	0.00169	0.00182	CcSEcCtD
Moxifloxacin—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00168	0.00181	CcSEcCtD
Moxifloxacin—Haemoglobin—Docetaxel—head and neck cancer	0.00168	0.0018	CcSEcCtD
Moxifloxacin—Rhinitis—Docetaxel—head and neck cancer	0.00167	0.0018	CcSEcCtD
Moxifloxacin—Haemorrhage—Docetaxel—head and neck cancer	0.00167	0.00179	CcSEcCtD
Moxifloxacin—Hepatitis—Docetaxel—head and neck cancer	0.00167	0.00179	CcSEcCtD
Moxifloxacin—Hypoaesthesia—Docetaxel—head and neck cancer	0.00166	0.00178	CcSEcCtD
Moxifloxacin—Confusional state—Fluorouracil—head and neck cancer	0.00166	0.00178	CcSEcCtD
Moxifloxacin—Pharyngitis—Docetaxel—head and neck cancer	0.00166	0.00178	CcSEcCtD
Moxifloxacin—Dizziness—Vinblastine—head and neck cancer	0.00166	0.00178	CcSEcCtD
Moxifloxacin—Urinary tract disorder—Docetaxel—head and neck cancer	0.00165	0.00177	CcSEcCtD
Moxifloxacin—Oedema peripheral—Docetaxel—head and neck cancer	0.00164	0.00177	CcSEcCtD
Moxifloxacin—Oedema—Fluorouracil—head and neck cancer	0.00164	0.00176	CcSEcCtD
Moxifloxacin—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00164	0.00176	CcSEcCtD
Moxifloxacin—Connective tissue disorder—Docetaxel—head and neck cancer	0.00164	0.00176	CcSEcCtD
Moxifloxacin—Asthenia—Hydroxyurea—head and neck cancer	0.00164	0.00176	CcSEcCtD
Moxifloxacin—Urethral disorder—Docetaxel—head and neck cancer	0.00164	0.00176	CcSEcCtD
Moxifloxacin—Nervous system disorder—Fluorouracil—head and neck cancer	0.00161	0.00173	CcSEcCtD
Moxifloxacin—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00161	0.00173	CcSEcCtD
Moxifloxacin—Visual impairment—Docetaxel—head and neck cancer	0.00161	0.00173	CcSEcCtD
Moxifloxacin—Tachycardia—Fluorouracil—head and neck cancer	0.0016	0.00172	CcSEcCtD
Moxifloxacin—Vomiting—Vinblastine—head and neck cancer	0.00159	0.00171	CcSEcCtD
Moxifloxacin—Erythema multiforme—Docetaxel—head and neck cancer	0.00158	0.0017	CcSEcCtD
Moxifloxacin—Headache—Vinblastine—head and neck cancer	0.00157	0.00168	CcSEcCtD
Moxifloxacin—Anorexia—Fluorouracil—head and neck cancer	0.00157	0.00168	CcSEcCtD
Moxifloxacin—Diarrhoea—Hydroxyurea—head and neck cancer	0.00156	0.00168	CcSEcCtD
Moxifloxacin—Eye disorder—Docetaxel—head and neck cancer	0.00156	0.00168	CcSEcCtD
Moxifloxacin—Cardiac disorder—Docetaxel—head and neck cancer	0.00155	0.00166	CcSEcCtD
Moxifloxacin—Hypotension—Fluorouracil—head and neck cancer	0.00154	0.00165	CcSEcCtD
Moxifloxacin—Angiopathy—Docetaxel—head and neck cancer	0.00151	0.00163	CcSEcCtD
Moxifloxacin—TOP2A—Gastric Cancer Network 1—NOTCH1—head and neck cancer	0.00151	0.0579	CbGpPWpGaD
Moxifloxacin—Dizziness—Hydroxyurea—head and neck cancer	0.00151	0.00162	CcSEcCtD
Moxifloxacin—Immune system disorder—Docetaxel—head and neck cancer	0.00151	0.00162	CcSEcCtD
Moxifloxacin—Mediastinal disorder—Docetaxel—head and neck cancer	0.0015	0.00162	CcSEcCtD
Moxifloxacin—Chills—Docetaxel—head and neck cancer	0.0015	0.00161	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.0015	0.00161	CcSEcCtD
Moxifloxacin—Arrhythmia—Docetaxel—head and neck cancer	0.00149	0.0016	CcSEcCtD
Moxifloxacin—Nausea—Vinblastine—head and neck cancer	0.00149	0.0016	CcSEcCtD
Moxifloxacin—Insomnia—Fluorouracil—head and neck cancer	0.00149	0.0016	CcSEcCtD
Moxifloxacin—Paraesthesia—Fluorouracil—head and neck cancer	0.00148	0.00158	CcSEcCtD
Moxifloxacin—Dyspnoea—Fluorouracil—head and neck cancer	0.00146	0.00157	CcSEcCtD
Moxifloxacin—Mental disorder—Docetaxel—head and neck cancer	0.00146	0.00157	CcSEcCtD
Moxifloxacin—Somnolence—Fluorouracil—head and neck cancer	0.00146	0.00157	CcSEcCtD
Moxifloxacin—Malnutrition—Docetaxel—head and neck cancer	0.00145	0.00156	CcSEcCtD
Moxifloxacin—Erythema—Docetaxel—head and neck cancer	0.00145	0.00156	CcSEcCtD
Moxifloxacin—Vomiting—Hydroxyurea—head and neck cancer	0.00145	0.00156	CcSEcCtD
Moxifloxacin—Dyspepsia—Fluorouracil—head and neck cancer	0.00145	0.00155	CcSEcCtD
Moxifloxacin—Rash—Hydroxyurea—head and neck cancer	0.00144	0.00155	CcSEcCtD
Moxifloxacin—Dermatitis—Hydroxyurea—head and neck cancer	0.00144	0.00154	CcSEcCtD
Moxifloxacin—Headache—Hydroxyurea—head and neck cancer	0.00143	0.00154	CcSEcCtD
Moxifloxacin—Decreased appetite—Fluorouracil—head and neck cancer	0.00143	0.00153	CcSEcCtD
Moxifloxacin—Dysgeusia—Docetaxel—head and neck cancer	0.00142	0.00153	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00142	0.00152	CcSEcCtD
Moxifloxacin—Back pain—Docetaxel—head and neck cancer	0.00141	0.00151	CcSEcCtD
Moxifloxacin—Pain—Fluorouracil—head and neck cancer	0.00141	0.00151	CcSEcCtD
Moxifloxacin—Muscle spasms—Docetaxel—head and neck cancer	0.0014	0.0015	CcSEcCtD
Moxifloxacin—Nausea—Hydroxyurea—head and neck cancer	0.00136	0.00146	CcSEcCtD
Moxifloxacin—Feeling abnormal—Fluorouracil—head and neck cancer	0.00135	0.00145	CcSEcCtD
Moxifloxacin—Anaemia—Docetaxel—head and neck cancer	0.00134	0.00144	CcSEcCtD
Moxifloxacin—Urticaria—Fluorouracil—head and neck cancer	0.00131	0.0014	CcSEcCtD
Moxifloxacin—Syncope—Docetaxel—head and neck cancer	0.0013	0.0014	CcSEcCtD
Moxifloxacin—Leukopenia—Docetaxel—head and neck cancer	0.0013	0.0014	CcSEcCtD
Moxifloxacin—Body temperature increased—Fluorouracil—head and neck cancer	0.0013	0.0014	CcSEcCtD
Moxifloxacin—Palpitations—Docetaxel—head and neck cancer	0.00128	0.00138	CcSEcCtD
Moxifloxacin—Loss of consciousness—Docetaxel—head and neck cancer	0.00128	0.00137	CcSEcCtD
Moxifloxacin—Cough—Docetaxel—head and neck cancer	0.00127	0.00136	CcSEcCtD
Moxifloxacin—Convulsion—Docetaxel—head and neck cancer	0.00126	0.00135	CcSEcCtD
Moxifloxacin—Hypertension—Docetaxel—head and neck cancer	0.00125	0.00135	CcSEcCtD
Moxifloxacin—Chest pain—Docetaxel—head and neck cancer	0.00124	0.00133	CcSEcCtD
Moxifloxacin—Arthralgia—Docetaxel—head and neck cancer	0.00124	0.00133	CcSEcCtD
Moxifloxacin—Myalgia—Docetaxel—head and neck cancer	0.00124	0.00133	CcSEcCtD
Moxifloxacin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00123	0.00132	CcSEcCtD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CCNA1—head and neck cancer	0.00122	0.0467	CbGpPWpGaD
Moxifloxacin—Hypersensitivity—Fluorouracil—head and neck cancer	0.00121	0.0013	CcSEcCtD
Moxifloxacin—Dry mouth—Docetaxel—head and neck cancer	0.00121	0.0013	CcSEcCtD
Moxifloxacin—Confusional state—Docetaxel—head and neck cancer	0.0012	0.00128	CcSEcCtD
Moxifloxacin—Anaphylactic shock—Docetaxel—head and neck cancer	0.00119	0.00127	CcSEcCtD
Moxifloxacin—Oedema—Docetaxel—head and neck cancer	0.00119	0.00127	CcSEcCtD
Moxifloxacin—Shock—Docetaxel—head and neck cancer	0.00117	0.00125	CcSEcCtD
Moxifloxacin—Nervous system disorder—Docetaxel—head and neck cancer	0.00116	0.00125	CcSEcCtD
Moxifloxacin—Pruritus—Fluorouracil—head and neck cancer	0.00116	0.00125	CcSEcCtD
Moxifloxacin—Thrombocytopenia—Docetaxel—head and neck cancer	0.00116	0.00125	CcSEcCtD
Moxifloxacin—Tachycardia—Docetaxel—head and neck cancer	0.00116	0.00124	CcSEcCtD
Moxifloxacin—Skin disorder—Docetaxel—head and neck cancer	0.00115	0.00124	CcSEcCtD
Moxifloxacin—Anorexia—Docetaxel—head and neck cancer	0.00113	0.00121	CcSEcCtD
Moxifloxacin—Diarrhoea—Fluorouracil—head and neck cancer	0.00112	0.00121	CcSEcCtD
Moxifloxacin—Hypotension—Docetaxel—head and neck cancer	0.00111	0.00119	CcSEcCtD
Moxifloxacin—Dizziness—Fluorouracil—head and neck cancer	0.00109	0.00117	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00108	0.00116	CcSEcCtD
Moxifloxacin—Insomnia—Docetaxel—head and neck cancer	0.00107	0.00115	CcSEcCtD
Moxifloxacin—Paraesthesia—Docetaxel—head and neck cancer	0.00106	0.00114	CcSEcCtD
Moxifloxacin—Dyspnoea—Docetaxel—head and neck cancer	0.00106	0.00114	CcSEcCtD
Moxifloxacin—Somnolence—Docetaxel—head and neck cancer	0.00105	0.00113	CcSEcCtD
Moxifloxacin—Vomiting—Fluorouracil—head and neck cancer	0.00104	0.00112	CcSEcCtD
Moxifloxacin—Dyspepsia—Docetaxel—head and neck cancer	0.00104	0.00112	CcSEcCtD
Moxifloxacin—Rash—Fluorouracil—head and neck cancer	0.00104	0.00111	CcSEcCtD
Moxifloxacin—Dermatitis—Fluorouracil—head and neck cancer	0.00103	0.00111	CcSEcCtD
Moxifloxacin—Decreased appetite—Docetaxel—head and neck cancer	0.00103	0.00111	CcSEcCtD
Moxifloxacin—Headache—Fluorouracil—head and neck cancer	0.00103	0.00111	CcSEcCtD
Moxifloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—NOTCH1—head and neck cancer	0.00103	0.0394	CbGpPWpGaD
Moxifloxacin—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00102	0.0011	CcSEcCtD
Moxifloxacin—Fatigue—Docetaxel—head and neck cancer	0.00102	0.0011	CcSEcCtD
Moxifloxacin—Pain—Docetaxel—head and neck cancer	0.00101	0.00109	CcSEcCtD
Moxifloxacin—Constipation—Docetaxel—head and neck cancer	0.00101	0.00109	CcSEcCtD
Moxifloxacin—Feeling abnormal—Docetaxel—head and neck cancer	0.000977	0.00105	CcSEcCtD
Moxifloxacin—Nausea—Fluorouracil—head and neck cancer	0.000976	0.00105	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00097	0.00104	CcSEcCtD
Moxifloxacin—Body temperature increased—Docetaxel—head and neck cancer	0.000937	0.00101	CcSEcCtD
Moxifloxacin—Abdominal pain—Docetaxel—head and neck cancer	0.000937	0.00101	CcSEcCtD
Moxifloxacin—Hypersensitivity—Docetaxel—head and neck cancer	0.000874	0.000939	CcSEcCtD
Moxifloxacin—Asthenia—Docetaxel—head and neck cancer	0.000851	0.000914	CcSEcCtD
Moxifloxacin—Pruritus—Docetaxel—head and neck cancer	0.000839	0.000901	CcSEcCtD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TYMS—head and neck cancer	0.000835	0.032	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.000815	0.0313	CbGpPWpGaD
Moxifloxacin—Diarrhoea—Docetaxel—head and neck cancer	0.000811	0.000872	CcSEcCtD
Moxifloxacin—Dizziness—Docetaxel—head and neck cancer	0.000784	0.000842	CcSEcCtD
Moxifloxacin—Vomiting—Docetaxel—head and neck cancer	0.000754	0.00081	CcSEcCtD
Moxifloxacin—TOP2A—Gastric Cancer Network 2—EGFR—head and neck cancer	0.000753	0.0289	CbGpPWpGaD
Moxifloxacin—Rash—Docetaxel—head and neck cancer	0.000748	0.000803	CcSEcCtD
Moxifloxacin—Dermatitis—Docetaxel—head and neck cancer	0.000747	0.000802	CcSEcCtD
Moxifloxacin—Headache—Docetaxel—head and neck cancer	0.000743	0.000798	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.000741	0.0285	CbGpPWpGaD
Moxifloxacin—Nausea—Docetaxel—head and neck cancer	0.000704	0.000757	CcSEcCtD
Moxifloxacin—TOP2A—Gastric Cancer Network 2—TP53—head and neck cancer	0.000632	0.0243	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—TYMS—head and neck cancer	0.000588	0.0226	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CCNA1—head and neck cancer	0.000447	0.0171	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.000445	0.0171	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—TYMS—head and neck cancer	0.000427	0.0164	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—head and neck cancer	0.000421	0.0161	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—CCNA1—head and neck cancer	0.000399	0.0153	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—RAD51—head and neck cancer	0.000321	0.0123	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	0.000304	0.0117	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CCND1—head and neck cancer	0.000296	0.0114	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—head and neck cancer	0.000277	0.0106	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	0.000261	0.01	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	0.000248	0.00952	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	0.000224	0.0086	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	0.000216	0.0083	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—TYMS—head and neck cancer	0.000216	0.00827	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—PTEN—head and neck cancer	0.000208	0.00797	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	0.000195	0.0075	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—TYMS—head and neck cancer	0.000193	0.0074	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	0.000185	0.00709	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	0.000176	0.00675	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	0.000176	0.00675	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	0.000153	0.00586	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	0.000148	0.00567	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—TP53—head and neck cancer	0.000142	0.00544	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	0.000125	0.00478	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—head and neck cancer	0.000109	0.00416	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—CCND1—head and neck cancer	9.7e-05	0.00372	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—MAPK3—head and neck cancer	8.95e-05	0.00343	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—MAPK1—head and neck cancer	8.52e-05	0.00327	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—MAPK3—head and neck cancer	8e-05	0.00307	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—MAPK1—head and neck cancer	7.61e-05	0.00292	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—TP53—head and neck cancer	6.39e-05	0.00245	CbGpPWpGaD
